CLINICAL CANCER RESEARCH Journal
Overview
publication venue for
- Safety and Efficacy of Pembrolizumab in Combination with Acalabrutinib in Advanced Head and Neck Squamous Cell Carcinoma: Phase 2 Proof-of-Concept Study. 28:903-914. 2022
- Inhibiting Fatty Acid Synthase with Omeprazole to Improve Efficacy of Neoadjuvant Chemotherapy in Patients with Operable TNBC. 27:5810-5817. 2021
- Inhibiting Fatty Acid Synthase with Omeprazole to Improve Efficacy of Neoadjuvant Chemotherapy in Patients with Operable TNBC. 27:5810-5817. 2021
- A Randomized Phase II Trial of Epigenetic Priming with Guadecitabine and Carboplatin in Platinum-resistant, Recurrent Ovarian Cancer. 26:1009-1016. 2020
- Final Report of a Phase I Trial of Olaparib with Cetuximab and Radiation for Heavy Smoker Patients with Locally Advanced Head and Neck Cancer. 24:4949-4959. 2018
- A Phase I Clinical Trial of Guadecitabine and Carboplatin in Platinum-Resistant, Recurrent Ovarian Cancer: Clinical, Pharmacokinetic, and Pharmacodynamic Analyses. 24:2285-2293. 2018
- Niclosamide Inhibits Androgen Receptor Variants Expression and Overcomes Enzalutamide Resistance in Castration-Resistant Prostate Cancer. 20:3198-3210. 2014
- Effect of eIF3a on Response of Lung Cancer Patients to Platinum-Based Chemotherapy by Regulating DNA Repair. 17:4600-4609. 2011
- Fine Mapping of Chromosome 6q23-25 Region in Familial Lung Cancer Families Reveals RGS17 as a Likely Candidate Gene. 15:2666-2674. 2009
- Interleukin-6 Regulates Androgen Synthesis in Prostate Cancer Cells. 15:4815-4822. 2009
- Population Pharmacokinetics of Romidepsin in Patients with Cutaneous T-Cell Lymphoma and Relapsed Peripheral T-Cell Lymphoma. 15:1496-1503. 2009
- ABCB1 Genetic Variation Influences the Toxicity and Clinical Outcome of Patients with Androgen-Independent Prostate Cancer Treated with Docetaxel. 14:4543-4549. 2008
- Antiestrogenic glyceollins suppress human breast and ovarian carcinoma tumorigenesis. 12:7159-7164. 2006
- Antiestrogenic Glyceollins Suppress Human Breast and Ovarian Carcinoma Tumorigenesis. 12:7159-7164. 2006
- Prostate-Specific Antigen Modulates Genes Involved in Bone Remodeling and Induces Osteoblast Differentiation of Human Osteosarcoma Cell Line SaOS-2. 12:1420-1430. 2006
- Correction: Niclosamide Inhibits Androgen Receptor Variants Expression and Overcomes Enzalutamide Resistance in Castration-Resistant Prostate Cancer 2017
- TARGETING THE FORMIN-ASSEMBLED ACTIN CYTOSKELETON AS AN ANTI-INVASION STRATEGY IN OVARIAN CANCER SPHEROIDS 2019
Research
category
- ONCOLOGY Category
Identity
International Standard Serial Number (ISSN)
- 1078-0432
Electronic International Standard Serial Number (EISSN)
- 1557-3265
Other
journal abbreviation
- CLIN CANCER RES